Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mortality rate of critically ill COVID-19 patients is high, especially in those requiring invasive mechanical ventilation. However, the causes and the timing of death of patients admitted to the ICU for SARS-CoV-2 pneumonia have been poorly reported [1, 2]. Whether patients mainly die from refractory respiratory failure directly due to SARS-CoV-2 pneumonia or from sepsis as reported in non-COVID-19 ARDS patients [3] is unknown. Moreover, the increased risk of pulmonary embolism extensively described among COVID-19 patients together with the SARS-CoV-2-associated myocardial injuries [4] may expose critically ill COVID-19 patients to death from a cardiac origin [5]. Additionally, the increased intensity of thromboprophylaxis commonly used to prevent thrombotic events might also promote fatal hemorrhagic events.
We therefore aimed to describe the main causes of death among critically ill COVID-19 patients admitted to our ICU, as well as to report the timing of each cause of death.
Anzeige
We retrospectively reviewed all deaths occurring in adult COVID-19 patients (RT-PCR positive for SARS-CoV-2) admitted to our ICU between March 6th, 2020 and January 18th, 2021 for acute respiratory failure related to SARS-CoV-2 pneumonia.
Causes of death were categorized in four subgroups: (1) refractory respiratory failure, (2) shock with multiorgan failure, (3) cardiac death including proven pulmonary embolism (proximal thrombus on CT-pulmonary angiography with acute cor pulmonale on echocardiography and vasopressor requirement) and unexpected cardiac arrest (neither prior oxygen desaturation nor circulatory failure) and (4) neurological death (ischemic/hemorrhagic stroke with brain herniation).
After exclusion of COVID-19 patients still hospitalized, 152 patients were analyzed. Among them, 73 (48%, 95% confidence interval 40–56%) died with a median delay of 14 [9–23] days after ICU admission. Characteristics of the patients dying in the ICU are detailed in the Table 1.
Table 1
Characteristics of 73 critically ill COVID-19 patients dying during ICU stay
COVID-19 patients dying in ICU
N = 73
Patient’s characteristics and ICU scores
Male sex
56 (77)
Age, years
68 [62–73]
SAPS II upon ICU admission
37 [29–45]
SOFA upon ICU admission
4 [3–8]
Main comorbidities
Arterial hypertension
52 (71)
Diabetes mellitus
35 (48)
Ischemic cardiopathy
10 (14)
Chronic respiratory disease
18 (25)
Immunocompromised status
18 (25)
Main delays
Days between disease onset and ICU admission
8 [6–11]
> 7 days between disease onset and ICU admission
51 (70)
Biological data upon ICU admission
D-dimers (ng/mL)
2505 [1555–5877]
Fibrinogen (g/L)
7.3 [5.6–8.5]
Treatment administered upon ICU admission
Glucocorticoids
35 (48)
Intermediate or full-dose thromboprophylaxis
53 (73)
Antibiotic therapy for bacterial co-infection at ICU admission
20 (27)
Antiviral drugs (lopinavir-ritonavir or remdesivir)
0 (0)
Tocilizumab
0 (0)
Outcome in the ICU
Invasive mechanical ventilation (IMV)
71 (97)
Days between ICU admission and IMV
2 [1–4]
Days between disease onset and IMV
11 [8–14]
Ventilator associated pneumonia
47 (64)
Prone positioning
62 (85)
Extra corporal membrane oxygenation
3 (4)
Tracheostomy
2 (3)
Renal replacement therapy
26 (36)
Vasopressor support
64 (88)
Thrombotic events during ICU stay
26 (36)
Hemorrhagic events during ICU stay
17 (23)
Delay between ICU admission and death, days
14 [9–23]
Continuous variables are reported as medians [quartile 1–quartile 3] and categorical variables are reported as numbers (percentages)
ACE/ARB Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers, ICU Intensive Care Unit, IMV Invasive Mechanical Ventilation, SAPS2 Simplified Acute Physiology Score, SOFA Sequential Organ Failure Assessment
Distribution of the main causes of death (panel a) and timing of each cause of death (panel b) are detailed in the Fig. 1. The leading cause of death was refractory respiratory failure which accounted for 45% of ICU deaths. Cardiac deaths (all occurring in intubated patients) included 4 pulmonary embolisms (intravenous thrombolysis, n = 3) and 9 unexpected cardiac arrests (asystole, n = 7; pulseless electrical activity, n = 2). Neurological deaths included hemorrhagic (n = 4) and ischemic (n = 1) strokes. Overall, 10 (14%) and 6 (8%) patients directly died from a thrombotic or hemorrhagic event, respectively.
×
Anzeige
None of the patients dying from shock with multi-organ failure or from cardiac death died after a withholding (all the patients with unexpected cardiac arrest underwent cardiopulmonary resuscitation) or withdrawal procedure while all patients dying from a neurological cause died after a withdrawal procedure. Among patients dying from refractory respiratory failure, 22 (66%) and 4 died after a withholding (tracheal intubation, n = 2; extracorporeal membrane oxygenation, n = 19; renal replacement therapy, n = 1) or withdrawal procedure, respectively.
As opposed to non-COVID19 ARDS patients [3, 6], we herein report that refractory respiratory failure was the leading cause of death among COVID-19 ARDS patients, consistent with a previous report [2]. Deaths by refractory respiratory failure occurred late in the ICU course, potentially as a result of pulmonary fibrosis induced by SARS-CoV-2 and prolonged mechanical ventilation, making futile the use of extracorporeal membrane oxygenation support.
Noteworthy, cardiac deaths related to pulmonary embolism or unexpected cardiac arrest accounted for 18% of the deaths and occurred early in the ICU course. Similarly, a large multicenter study reported that up to 14% of the critically ill COVID-19 patients experienced cardiac arrest, mainly due to pulseless electrical activity and asystole, as a possible manifestation of fulminant myocarditis or proximal pulmonary embolism [2, 5].
Even if our study suffers from several limitations including its monocenter retrospective design, the limited number of patients and the lack of control with non-COVID-19 patients, it provides an informative picture of the main causes of death of critically ill COVID-19 patients.
Acknowledgements
We warmly acknowledge Dr. Jo-Anna Tirolien, Dr. Olivia Picq, Dr. Olivier Pajot, Dr. Hervé Mentec and all the residents who cared of the patients.
Ethics approval and consent to participate
This study was conducted in accordance with the amended Declaration of Helsinki and was approved by the Institutional Review Board (CE 2021-008) of the French Intensive Care Society.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Anzeige
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.
Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.
Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.
Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.
Update AINS
Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.